18 completed. 18 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 18 |
| Phase 2 | 1 | Completed 1 |
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza ZX-7101A for oral suspension, Oseltamivir phosphate for oral suspension - Respiratory Viral Infection | Phase 3 | Completed | Nanjing Zenshine Pharmaceuticals | 169 | 2025-10-13 | 2026-04-16 |
| Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects Patiromer Powder for Oral Suspension (Part A), Placebo (Part B), Patiromer Powder for Orals Suspension (Part B) - Hyperkalemia, Renal Insufficiency, Chronic | Phase 3 | Completed | Vifor Fresenius Medical Care Renal Pharma | 262 | 2022-02-10 | 2026-04-13 |
| Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions. Ibuprofen suspension 5mg/100ml, Placebos - Oral Lichen Planus, Oral Lichenoid Mucositis | Phase 2 / Phase 3 | Completed | University of Washington | 23 | 2018-04-29 | 2020-05-08 |
| Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies spinosad topical suspension, 0.9%, Placebo - Scabies | Phase 3 | Completed | ParaPRO LLC | 280 | 2017-05-10 | 2021-05-21 |
| Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies spinosad topical suspension, 0.9%, Placebo - Scabies | Phase 3 | Completed | ParaPRO LLC | 291 | 2017-05-02 | 2021-05-19 |
| Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL fixed combination eye drops, suspension, Brinzolamide 10 mg/mL eye drops, suspension, Brimonidine 2 mg/mL eye drops, solution - Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Alcon Research | 493 | 2015-04-14 | 2018-07-02 |
| A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) Patiromer, Placebo - Chronic Kidney Disease (CKD), Hyperkalemia (HK) | Phase 3 | Completed | Relypsa, Inc. | 243 | 2013-02-01 | 2021-06-03 |
| beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study beclomethasone dipropionate 800 mcg/2 ml suspension for nebulization,one administration b.i.d. for 14 days, placebo 2 ml suspension for nebulization, one administration b.i.d. for 14 days - Acute Rhinosinusitis | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 166 | 2013-01-01 | 2017-03-29 |
| A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) Aprepitant 125 mg, Aprepitant 80 mg, Aprepitant powder for suspension (PFS) - Chemotherapy Induced Nausea and Vomiting | Phase 3 | Completed | Merck Sharp & Dohme LLC | 307 | 2011-09-13 | 2018-09-25 |
| LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Calcipotriol plus betamethasone, Betamethasone-17,21-dipropionate, Calcipotriene - Psoriasis Vulgaris | Phase 3 | Completed | LEO Pharma | 1152 | 2010-09-01 | 2025-03-10 |
| Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice Spinosad, Permethrin 1% - Pediculosis | Phase 3 | Completed | ParaPRO LLC | 558 | 2007-09-01 | 2012-10-11 |
| Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice Spinosad, Permethrin 1% - Pediculus Capitis Infestation | Phase 3 | Completed | ParaPRO LLC | 480 | 2007-09-01 | 2012-10-11 |
| Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly Octreotide acetate 30 mg suspension - Acromegaly | Phase 3 | Completed | Novartis Pharmaceuticals | 28 | 2005-12-01 | 2011-05-17 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension, Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension, Timolol 5 mg/ml eye drops, solution - Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Alcon Research | 523 | 2005-11-01 | 2016-11-18 |
| Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo Nepafenac 1mg/ml eye drops, suspension, Ketorolac Trometamol 5 mg/ml eye drops, solution, Nepafenac vehicle eye drops - Cataracts | Phase 3 | Completed | Alcon Research | 227 | 2005-11-01 | 2016-11-18 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension, Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT) - Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Alcon Research | 437 | 2005-10-01 | 2016-11-18 |
| Breastfeeding, Antiretroviral, and Nutrition Study Maternal zidovudine/lamivudine/lopinavir-ritonavir, Infant nevirapine, Maternal protein and calorie supplement - HIV Infections | Phase 3 | Completed | Centers for Disease Control and Prevention | 2369 | 2004-03-01 | 2010-04-23 |
| Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B Adefovir Dipivoxil for oral suspension, 2 mg/mL - Chronic Hepatitis B | Phase 3 | Completed | Gilead Sciences | 48 | 2003-06-01 | 2013-10-16 |
Glaucoma, Open-Angle (3) · Ocular Hypertension (3) · Hyperkalemia (2) · Renal Insufficiency, Chronic (2) · Scabies (2) · Acromegaly (1) · Breast Feeding (1) · Cataract (1) · HIV Infections (1) · Hepatitis B, Chronic (1) · Lice Infestations (1) · Lichen Planus, Oral (1) · Oral Ulcer (1) · Vomiting (1)
Alcon Research (4) · ParaPRO LLC (4) · Centers for Disease Control and Prevention (1) · Chiesi Farmaceutici S.p.A. (1) · Gilead Sciences (1) · LEO Pharma (1) · Merck Sharp & Dohme LLC (1) · Nanjing Zenshine Pharmaceuticals (1) · Novartis Pharmaceuticals (1) · Relypsa, Inc. (1) · University of Washington (1) · Vifor Fresenius Medical Care Renal Pharma (1)
United States (9) · Italy (3) · China (2) · Croatia (1) · Czechia (1) · Denmark (1) · France (1) · Georgia (1) · Hungary (1) · Malawi (1) · Serbia (1) · Slovenia (1) · Ukraine (1)
Bill Miller, MD (2) · Kerry W Mettert, MBA (2) · Alan Menter, MD (1) · Alicia Bucko, MD (1) · Amy M Morris, MD (1) · Andrew King, MD (1) · Brent M Boyce, MD (1) · Catherine Hren, MD (1) · Charles P Hudson, MD (1) · Charles van der Horst, MD (1) · Chernila Selbert Alan, MD (1) · Dale Martin, MD (1) · Daniel M Stewart, DO (1)
PMID 18538406, PMID 19365194, PMID 19668532, PMID 20554982, PMID 21212103, PMID 22541418, PMID 22649265, PMID 23468553, PMID 23700341, PMID 24381222, PMID 24500152, PMID 25723140, PMID 25770814, PMID 26156797, PMID 29893452, PMID 32588430
2005 (1)